List of Publications -2010

988. Babu S, Bhat SQ, Kumar NP, Kumaraswami V, Nutman TB. Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results. J Infect Dis.2010;201:20-31.

989. Kwara A, Ramachandran G, Swaminathan S. Dose adjustment of the non- nucleoside reverse transcriptase inhibitors during concurrent rifampicin- containing tuberculosis therapy: one size does not fit all. Expert Opin Drug Metab Toxicol.2010;6:55-68.

990. Basirudeen S, Rajasekaran S, Raja A. Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS.2010;24:323-325.

991. Rao PV, Rajasekaran S, Raja A. Natural killer cell-mediated cytokine response among HIV-positive south Indians with pulmonary tuberculosis. J Interferon Cytokine Res.2010;30:33-41.

992. Kumar M, Meenakshi N, Sundaramurthi JC, Kaur G, Mehra NK, Raja A. Immune response to Mycobacterium tuberculosis specific antigen ESAT-6 among south Indians. Tuberculosis.2010 ; 90:6069.

993. Swaminathan S. Evidence based treatment of tuberculosis for children the unfinished agenda. Indian Pediatr.2010;47:39-40.

994. Anand SP, Harishankar M, Selvaraj P. Interferon gamma gene +874A/T polymorphism and intracellular interferon gamma expression in pulmonary tuberculosis. Cytokine.2010;49:130133.

995. Paramasivan CN, Rehman F, Wares F, Mohan NS, Sundar S, Devi S, Narayanan PR. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India. Int J Tuber Lung Dis.2010;14:243246.

996. Kumar M, Sundaramurthi JC, Mehra NK, Kaur G, Raja A. Cellular immune response to Mycobacterium tuberculosis -specific antigen culture filtrate protein10 in south India . Med Microbiol Immunol.2010; 199:11-25.

997. Anbarasu D, Sundaramurthi JC, Raja A. Immunological and proteomic analysis of preparative isoelectric focusing separated culture filtrate antigens of Mycobacterium tuberculosis . Exp Mol Pathol.2010;88:156-162.

998. Basirudeen SAK, Balambal R, Thomas A, Venkatesan P, Raja A. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One.2010;5:1-7.

999. Yim J, Selvaraj P. Genetic susceptibility in tuberculosis. Respirology.2010;15: 241256.

1000. Majumdar SD, Sharma D, Vashist A, Kaur K, Taneja NK, Chauhan S, Challu VK, Ramanathan VD, Balasangameshwara V, Kumar P, Tyagi JS. Co-expression of DevR and DevR N -Aph proteins is associated with hypoxic adaptation defect and virulence attenuation of Mycobacterium tuberculosis . PLoS one.2010;5:1-9.

1001. Venkatesan P, Srinivasan R. Modeling the spatial variogram of tuberculosis for Chennai ward in India . Indian J Sci Technol.2010;3:167-169 .

1002. Ponnuraja C, Venkatesan P. Correlated frailty model: an advantageous approach for covariate analysis of tuberculosis data. Indian J Sci Technol.2010;3:151- 155.

1003. Narayanan S, Swaminathan S, Supply P, Sivakumar S, Narendran G, Hari L, Ramachandran R, Locht C, Jawahar MS, Narayanan PR. Impact of HIV infection on the recurrence of tuberculosis in south India . J Infect Dis.2010;201:691-703.

1004. Rao VG, Bhat J, Yadav R, Gopi PG, Selvakumar N, Wares DF. Prevalence of pulmonary tuberculosis among the Bharia, a primitive tribe of Madhya Pradesh, central India . Int J Tuberc Lung Dis.2010;14:368-370.

1005. Subramanyam B, Dusthackeer A, Rehman F, Sekar G, Sivaramakrishnan GN, Kumar V. An alternative sputum processing method using chitin for the isolation of Mycobacterium tuberculosis . World J Microbiol Biotechnol.2010;26:523- 526.

1006. Radhakrishnan M, Suganya S, Balagurunathan R, Kumar V. Preliminary screening for antibacterial and antimycobacterial activity of actinomycetes fr om less explored ecosystems. World J Microbiol Biotechnol.2010;26:561-566.

1007. Anbarasu D, Heaslip D, Rajendiran AA, Velayudham BV, Frederick S, Yang HL, Dobos K, Belisle JT, Raja A. Immunoproteomic identification of human T cell antigens of Mycobacterium tuberculosis that differentiate healthy contacts from tuberculosis patients. Mol Cell Proteomics.2010;9:538-549.

1008. Swaminathan S, Narendran G, Venkatesan P, Iliayas S, Ramesh S, Menon PA, Padmapriyadarsini C, Ramachandran R, Ponnuraja C, Suhadev M, Sakthivel R, Narayanan PR. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis. A randomized clinical trial. Am J Respir Crit Care Med.2010;181:743-751.

1009. Sivakumar PM, Kumar V, Seenivasan SP, Mohanapriya J, Doble M. Experimental and theoretical approaches to enhance anti tubercular activity of Chalcones. WSEAS Transac Biol Biomed.2010;7:51-61.

1010. Ray D, Subramanyam S, Krishna SH, Ramanathan VD. Serum C3d levels in tropical pulmonary eosinophilia. Indian J Med Res.2010;131:555-558.

1011. Joseph J, Hassan S, Rajendran V, Kumar V. Microbial genome databases: A user's perspective. Int J Pharma and Bio Sciences.2010;V1:1-9.

1012. Nalini S, Lakshmi R, Devika K, Ravikumar D, Ramachandran R. Combined drug medium with isoniazid and rifampicin for identification of multi-drug resistant Mycobacterium tuberculosis. Indian J Med Microbiol.2010;28:162-163.

1013. Yadav R, Rao VG, Bhat J, Gopi PG, Selvakumar N, Wares DF. Prevalence of pulmonary tuberculosis amongst the Baigas A primitive tribe of Madhya Pradesh, Central India . Indian J Tuberc.2010;57:114-116.

1014. Swaminathan S, Padmapriyadarsini C, Narendran G. HIV-associated tuberculosis: Clinical update. Clin Infect Dis.2010;50:1377-1386.

1015. Swaminathan S, Rekha B. Pediatric tuberculosis: Global overview and challenges. Clin Infect Dis.2010;50:S184S194.

1016. Sivakumar PM, Seenivasan SP, Kumar V, Double M. Novel 1,3,5-triphenyl- 2pyrazolines as anti-infective agents. Bioorg Med Chem Lett.2010;20:3169- 3172.

1017. Hassan S, Dusthackeer A, Subramanyam B, Ponnuraja C, Sivaramakrishnan GN, Kumar V. Lytic efficiency of mycobacteriophages. The Open Systems Biol J.2010;3:21-28.

1018. Ramana Rao PV, Ramanavelan S, Rajasekaran S, Raja A. Natural-killer cell- derived cytolytic molecules in HIV-associated pulmonary tuberculosis Role of exogenous interleukins. J Clin Immunol.2010;30:393-401.

1019. Suresh ML, Venkatesan P. Comparison of artificial neural network with regression models for prediction of survival after surgery in cancer patients. Int J Inf Sci Computer Maths.2010;1:137-146.

1020. Basirudeen S, Venkatesan P, Paulkumaran P, Raja A. Yield of QuantiFERON- TB gold in tube assay and tuberculin skin test in healthy persons from a tuberculosis endemic population. J Pediatr Infect Dis.2010;5:125-129.

1021. Aravindhan V, Mohan V, Surendar J, Rao MM, Pavankumar N, Deepa M, Rajagopalan R, Kumaraswami V, Nutman TB, Babu S. Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro- inflammatory cytokine response (CURES 83). PLoS Negl Trop Dis.2010;4:1- 6.

1022. Padmapriyadarsini C, Swaminathan S, Karthipriya MJ, Narendran G, Menon PA, Thomas BE. Morphologic and body composition changes are different in men and women on generic combination antiretroviral therapy an observational study. J Assoc Physicians India.2010;58:375-377.

1023. Gopi PG, Vasantha M, Muniyandi M. Assessment of X-ray readers in TB prevalence surveys. J Commun Dis.2010;42:191-199.

1024. Rama R, Swaminathan R, Venkatesan P. Cure models for estimating hospital- based breast cancer survival. Asian Pacific J Cancer Prev.2010;11:387-391.

1025. Swaminathan S, Padmapriyadarsini C, Yoojin L, Sukumar B, Iliayas S, Karthipriya J, Sakthivel R, Gomathy P, Thomas BE, Mathew M, Wanke CA, Narayanan PR. Nutritional supplementation in HIV-infected individuals in south India: A prospective interventional study. Clin Infect Dis.2010;51:51-57.

1026. Priya R, Das SD. Kinetics of chemokine secretion in human macrophages infected with various strains of Mycobacterium tuberculosis . Indian J Med Microbiol.2010;28:201-206.

1027. Goletti D, Raja A, Basirudeen S, Rodrigues C, Sodha A, Butera O, Carrara S, Vernet G, Longuet C, Ippolito G, Thangaraj S, Leportier M, Girardi E, Lagrange PH. IFN- γ , but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect.2010;61:133-143.

1028. Ramachandran R, Muniyandi M, Gopi PG, Wares F. Why do tuberculosis suspects bypass local services to attend tuberculosis sanatorium? Lung India.2010;27:111-114.

1029. Ponnuraja C, Venkatesan P. Survival models for exploring tuberculosis clinical trial data-an empirical comparison. Ind J Sci Technol.2010;3:755-758.

1030. Rao VG, Gopi PG, Bhat J, Selvakumar N, Yadav R, Tiwari B, Gadge V, Bhondeley MK, Wares F. Pulmonary tuberculosis: a public health problem amongst the Saharia, a primitive tribe of Madhya Pradesh , Central India . Int J Infect Dis.2010;14:713-716.

1031 . Muniyandi M, Rajeswari R, Balasubramanian R, Thomas A, Santha T, Narayanan PR. India's Revised National Tuberculosis Control Programme (RNTCP): Budget and performance. J Health Management.2010;12:261271.

1032. Goletti D, Raja A, Basirudden S, Rodrigues C, Sodha A, Butera O, Carrara S, Vernet G, Longuet C, Ippolito G, Thangaraj S, Leportier M, Girardi E, Lagrange PH. Is IP-10 an accurate marker for detecting M. tuberculosis -specific response in HIV-infected persons? PLoS One.2010;5:1-9.

1033. Selvaraj P, Harishankar M, Singh B, Jawahar MS, Banurekha VV. Toll-like receptor and TIRAP gene polymorphisms in pulmonary tuberculosis patients of south India . Tuberculosis.2010;90:306-310

1034. Uhler LM, Kumarasamy N, Mayer KH, Saxena A, Losina E, Muniyandi M, Stoler AW, Lu Z, Walensky RP, Flanigan TP, Bender MA, Freedberg KA, Swaminathan S; CEPAC International investigators. Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India . PLoS One.2010;5:1-9.

1035. Charles N, Thomas BE, Watson B, Raja Sakthivel M, Chandrasekeran V, Wares F. Care seeking behavior of chest symptomatics: A community based study done in south India after the implementation of the RNTCP. PLoS ONE;2010:5:1- 6.

1036. Hemanth Kumar AK, Sudha V, Swaminathan S, Ramachandran G. Comparison of HPLC & spectrophotometric methods for estimation of antiretroviral drug content in pharmaceutical products. Indian J Med Res.2010;132: 390-394.

1037. Ramachandran G, Hemanth Kumar AK, Vasantha M, Shah I, Swaminathan S. Plasma Efavirenz in HIV infected children treated with generic antiretroviral drugs in India . Indian Pediatr.2010;47:890-891.

1038. Bennuru S, Maldarelli G, Kumaraswami V, Klion AD, Nutman TB. Elevated levels of plasma angiogenic factors are associated with human lymphatic filarial infections. Am J Trop Med Hyg.2010;83:884-890.

1039. Kumar M, Raja A. Cytotoxicity responses to selected ESAT-6 and CFP-10 peptides in tuberculosis. Cell Immunol.2010;265:146-155.

1040. Rajesh L, Ramesh K , Hanna LE, Narayanan PR, Swaminathan S. Emergence of drug resistant mutations after single dose nevirapine exposure in HIV-1 infected pregnant women in south India . Indian J Med Res.2010;132:509-512.

1041. Subramanyam B, Kumar V, Venkatesan P, Selvakumar N. Phage lysin to supplement phagebiotics to decontaminate processed sputum specimens. Eur J Clin Microbiol Infect Dis.2010;29:1407-1412.

1042. Senthamaraikannan K, Senthilkumar B, Ponnuraja, C, Venkatesan P. A Bayesian hierarchical model for longtitudinal data. Int J Cur Res.2010;10:12-20.

1043. Aravindhan V, Mohan V, Surendar J, Rao MM, Ranjani H, Kumaraswami V, Nutman TB, Babu S. Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes. Am J Trop Med Hyg.2010;83:1336-1339.

1044. Rao VG, Bhat J, Yadav R, Gopi PG, Selvakumar N, Wares DF. Diagnosis of pulmonary tuberculosis by symptoms among tribals in central India . Natl Med J India.2010:23:372-373.

1045. Muruganathan A, Thomas A, Muniyandi M, Chandrasekaran V. Revised National Tuberculosis Control Programme (RNTCP). J Indian Med Assoc.2010;108:868-870.

1046. Ponnuraja, C. An empirical investigation of meta-analysis using randomized controlled clinical trials in a particular centre. Journal of Applied Quantitative Methods in Medicine; 2010; 5; 1676-175.

 


2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013